ArticleJournal of public health in Africa2025
Barriers and enhancers to COVID-19 vaccination among healthcare workers in a metropolitan city in Nigeria.
Article in Journal of public health in Africa, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vaccine hesitancy among healthcare workers (HCWs) hinders coronavirus disease 2019 (COVID-19) control efforts. Aim: The aim of the study was to assess enhancers and barriers to the uptake of COVID-19 vaccine among HCWs in Ibadan, Nigeria. Setting: Health facility-based cross-sectional study in Ibadan, a metropolitan city in Oyo state, Nigeria. Methods: A questionnaire administered using REDCap assessed HCW vaccination status, attitudes and access using the Behavioural and Social drivers (BeSD) framework. Data analysis performed using STATA version 17 included descriptive statistics and modified Poisson regression. Results: Of the 1227 HCWs recruited, 82.8% received at least one dose. Vaccine uptake was higher among older HCWs compared to those below 25 years (45-54 years: prevalence ratio [PR] = 1.20, 95% confidence interval [CI]: 1.09, 1.33 and ≥ 55 years: PR = 1.17, 95% CI: 1.05, 1.30) and HCWs in private health centres (PR = 1.15, 95% CI: 1.08, 1.22). Most HCWs (83.5%) believed in vaccination for infectious diseases, but only 61.9% felt the same about COVID-19 vaccines. The major reasons for vaccine hesitancy among unvaccinated HCWs included the beliefs that vaccine development and authorisation were rushed (47 [26.1%]) and concerns about serious side effects (32 [17.8%]). Conclusion: This study found that the uncertainty about COVID-19 vaccine safety is a key barrier to its uptake. Therefore, targeted education and communication strategies to improve vaccine confidence are crucial. Contribution: This study identifies why HCWs in Nigeria are hesitant about getting vaccinated. This information can help to improve vaccination rates in this group. It fits with the journal's focus on making African public health responses stronger.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.